Atlas Trials

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Clinical trial NCT01352429 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01352429
Sponsor
Abramson Cancer Center at Penn Medicine
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Prostate Adenocarcinoma
Start date
2009-08-01
Primary completion
2026-12-01
Enrollment
303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.